Processa Pharmaceuticals, Inc. cotiza a 1.90 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distri…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-1.75 | $-6.25 | $-7.50 | $-18.50 |
| Estimado | $-2.00 | $-5.75 | $-19.25 | $-23.00 |
| Sorpresa | +12.5% | -8.7% | +61.0% | +19.6% |
| Métrica | PCSA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -243.2% | -40.4% | -202.8% |
| ROA | -173.6% | -32.0% | -141.6% |
| Current Ratio | 2.54 | 2.84 | -0.30 |
| Debt / Equity | — | 0.28 | — |